GO:0016571 | histone methylation | 30.22% (42/139) | 4.87 | 0.0 | 0.0 |
GO:0006259 | DNA metabolic process | 38.85% (54/139) | 3.84 | 0.0 | 0.0 |
GO:0008283 | cell proliferation | 31.65% (44/139) | 5.76 | 0.0 | 0.0 |
GO:0006275 | regulation of DNA replication | 25.9% (36/139) | 5.74 | 0.0 | 0.0 |
GO:0051052 | regulation of DNA metabolic process | 26.62% (37/139) | 5.18 | 0.0 | 0.0 |
GO:0006325 | chromatin organization | 35.25% (49/139) | 4.21 | 0.0 | 0.0 |
GO:0007017 | microtubule-based process | 30.22% (42/139) | 5.01 | 0.0 | 0.0 |
GO:0032506 | cytokinetic process | 35.25% (49/139) | 5.67 | 0.0 | 0.0 |
GO:0006479 | protein methylation | 30.22% (42/139) | 4.86 | 0.0 | 0.0 |
GO:0022402 | cell cycle process | 39.57% (55/139) | 4.33 | 0.0 | 0.0 |
GO:0034968 | histone lysine methylation | 30.22% (42/139) | 5.18 | 0.0 | 0.0 |
GO:0008213 | protein alkylation | 30.22% (42/139) | 4.86 | 0.0 | 0.0 |
GO:0061647 | histone H3-K9 modification | 29.5% (41/139) | 5.51 | 0.0 | 0.0 |
GO:0018022 | peptidyl-lysine methylation | 30.22% (42/139) | 5.17 | 0.0 | 0.0 |
GO:0016569 | covalent chromatin modification | 33.81% (47/139) | 4.55 | 0.0 | 0.0 |
GO:0000911 | cytokinesis by cell plate formation | 33.09% (46/139) | 5.61 | 0.0 | 0.0 |
GO:0000226 | microtubule cytoskeleton organization | 28.78% (40/139) | 5.05 | 0.0 | 0.0 |
GO:0016570 | histone modification | 33.81% (47/139) | 4.74 | 0.0 | 0.0 |
GO:1902410 | mitotic cytokinetic process | 35.25% (49/139) | 5.67 | 0.0 | 0.0 |
GO:0051567 | histone H3-K9 methylation | 29.5% (41/139) | 5.51 | 0.0 | 0.0 |
GO:1903047 | mitotic cell cycle process | 35.97% (50/139) | 5.47 | 0.0 | 0.0 |
GO:0018205 | peptidyl-lysine modification | 30.22% (42/139) | 4.62 | 0.0 | 0.0 |
GO:0006306 | DNA methylation | 25.18% (35/139) | 5.27 | 0.0 | 0.0 |
GO:0006305 | DNA alkylation | 25.18% (35/139) | 5.27 | 0.0 | 0.0 |
GO:0044728 | DNA methylation or demethylation | 25.18% (35/139) | 5.26 | 0.0 | 0.0 |
GO:0006304 | DNA modification | 25.18% (35/139) | 5.25 | 0.0 | 0.0 |
GO:0006260 | DNA replication | 27.34% (38/139) | 4.86 | 0.0 | 0.0 |
GO:0051726 | regulation of cell cycle | 28.06% (39/139) | 4.73 | 0.0 | 0.0 |
GO:0007010 | cytoskeleton organization | 29.5% (41/139) | 4.48 | 0.0 | 0.0 |
GO:0018193 | peptidyl-amino acid modification | 30.22% (42/139) | 4.38 | 0.0 | 0.0 |
GO:0043414 | macromolecule methylation | 31.65% (44/139) | 4.09 | 0.0 | 0.0 |
GO:0032259 | methylation | 31.65% (44/139) | 4.09 | 0.0 | 0.0 |
GO:0006270 | DNA replication initiation | 17.27% (24/139) | 6.2 | 0.0 | 0.0 |
GO:1901990 | regulation of mitotic cell cycle phase transition | 17.27% (24/139) | 6.13 | 0.0 | 0.0 |
GO:1901987 | regulation of cell cycle phase transition | 17.27% (24/139) | 6.13 | 0.0 | 0.0 |
GO:0007346 | regulation of mitotic cell cycle | 17.99% (25/139) | 5.59 | 0.0 | 0.0 |
GO:0016043 | cellular component organization | 51.8% (72/139) | 2.36 | 0.0 | 0.0 |
GO:0010389 | regulation of G2/M transition of mitotic cell cycle | 15.83% (22/139) | 6.1 | 0.0 | 0.0 |
GO:1902749 | regulation of cell cycle G2/M phase transition | 15.83% (22/139) | 6.1 | 0.0 | 0.0 |
GO:0006996 | organelle organization | 38.13% (53/139) | 3.04 | 0.0 | 0.0 |
GO:0010564 | regulation of cell cycle process | 18.71% (26/139) | 5.22 | 0.0 | 0.0 |
GO:0071840 | cellular component organization or biogenesis | 51.8% (72/139) | 2.26 | 0.0 | 0.0 |
GO:0016458 | gene silencing | 21.58% (30/139) | 4.3 | 0.0 | 0.0 |
GO:0090304 | nucleic acid metabolic process | 41.01% (57/139) | 2.5 | 0.0 | 0.0 |
GO:0048449 | floral organ formation | 16.55% (23/139) | 5.03 | 0.0 | 0.0 |
GO:1905393 | plant organ formation | 17.27% (24/139) | 4.62 | 0.0 | 0.0 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 19.42% (27/139) | 4.14 | 0.0 | 0.0 |
GO:0009909 | regulation of flower development | 20.14% (28/139) | 3.96 | 0.0 | 0.0 |
GO:0006464 | cellular protein modification process | 35.25% (49/139) | 2.54 | 0.0 | 0.0 |
GO:0036211 | protein modification process | 35.25% (49/139) | 2.54 | 0.0 | 0.0 |
GO:0006342 | chromatin silencing | 17.27% (24/139) | 4.34 | 0.0 | 0.0 |
GO:0006261 | DNA-dependent DNA replication | 16.55% (23/139) | 4.48 | 0.0 | 0.0 |
GO:0045814 | negative regulation of gene expression, epigenetic | 17.27% (24/139) | 4.32 | 0.0 | 0.0 |
GO:0048831 | regulation of shoot system development | 20.14% (28/139) | 3.82 | 0.0 | 0.0 |
GO:0048451 | petal formation | 12.23% (17/139) | 5.55 | 0.0 | 0.0 |
GO:0048453 | sepal formation | 12.23% (17/139) | 5.55 | 0.0 | 0.0 |
GO:0006139 | nucleobase-containing compound metabolic process | 41.73% (58/139) | 2.13 | 0.0 | 0.0 |
GO:0031047 | gene silencing by RNA | 16.55% (23/139) | 4.34 | 0.0 | 0.0 |
GO:2000241 | regulation of reproductive process | 20.14% (28/139) | 3.7 | 0.0 | 0.0 |
GO:0043412 | macromolecule modification | 36.69% (51/139) | 2.31 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 47.48% (66/139) | 1.86 | 0.0 | 0.0 |
GO:0040029 | regulation of gene expression, epigenetic | 17.27% (24/139) | 4.1 | 0.0 | 0.0 |
GO:0010629 | negative regulation of gene expression | 21.58% (30/139) | 3.43 | 0.0 | 0.0 |
GO:0010605 | negative regulation of macromolecule metabolic process | 22.3% (31/139) | 3.3 | 0.0 | 0.0 |
GO:0048580 | regulation of post-embryonic development | 20.14% (28/139) | 3.52 | 0.0 | 0.0 |
GO:0016572 | histone phosphorylation | 10.79% (15/139) | 5.59 | 0.0 | 0.0 |
GO:0009892 | negative regulation of metabolic process | 22.3% (31/139) | 3.24 | 0.0 | 0.0 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 18.71% (26/139) | 3.69 | 0.0 | 0.0 |
GO:0044267 | cellular protein metabolic process | 35.25% (49/139) | 2.24 | 0.0 | 0.0 |
GO:0046483 | heterocycle metabolic process | 41.73% (58/139) | 1.93 | 0.0 | 0.0 |
GO:0031048 | chromatin silencing by small RNA | 12.23% (17/139) | 4.88 | 0.0 | 0.0 |
GO:2000026 | regulation of multicellular organismal development | 20.14% (28/139) | 3.35 | 0.0 | 0.0 |
GO:0006346 | methylation-dependent chromatin silencing | 12.23% (17/139) | 4.85 | 0.0 | 0.0 |
GO:2000113 | negative regulation of cellular macromolecule biosynthetic process | 17.99% (25/139) | 3.64 | 0.0 | 0.0 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 17.99% (25/139) | 3.64 | 0.0 | 0.0 |
GO:0031327 | negative regulation of cellular biosynthetic process | 17.99% (25/139) | 3.6 | 0.0 | 0.0 |
GO:0009890 | negative regulation of biosynthetic process | 17.99% (25/139) | 3.59 | 0.0 | 0.0 |
GO:0051239 | regulation of multicellular organismal process | 20.14% (28/139) | 3.28 | 0.0 | 0.0 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 18.71% (26/139) | 3.46 | 0.0 | 0.0 |
GO:1902679 | negative regulation of RNA biosynthetic process | 17.27% (24/139) | 3.64 | 0.0 | 0.0 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 17.27% (24/139) | 3.64 | 0.0 | 0.0 |
GO:0045892 | negative regulation of transcription, DNA-templated | 17.27% (24/139) | 3.64 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 41.73% (58/139) | 1.85 | 0.0 | 0.0 |
GO:0051253 | negative regulation of RNA metabolic process | 17.27% (24/139) | 3.61 | 0.0 | 0.0 |
GO:0034645 | cellular macromolecule biosynthetic process | 27.34% (38/139) | 2.56 | 0.0 | 0.0 |
GO:0031324 | negative regulation of cellular metabolic process | 18.71% (26/139) | 3.4 | 0.0 | 0.0 |
GO:0050793 | regulation of developmental process | 23.02% (32/139) | 2.86 | 0.0 | 0.0 |
GO:0006725 | cellular aromatic compound metabolic process | 41.73% (58/139) | 1.79 | 0.0 | 0.0 |
GO:0009059 | macromolecule biosynthetic process | 28.06% (39/139) | 2.41 | 0.0 | 0.0 |
GO:1901360 | organic cyclic compound metabolic process | 41.73% (58/139) | 1.72 | 0.0 | 0.0 |
GO:0048523 | negative regulation of cellular process | 20.86% (29/139) | 2.94 | 0.0 | 0.0 |
GO:0003777 | microtubule motor activity | 9.35% (13/139) | 5.29 | 0.0 | 0.0 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 32.37% (45/139) | 2.1 | 0.0 | 0.0 |
GO:0010556 | regulation of macromolecule biosynthetic process | 32.37% (45/139) | 2.1 | 0.0 | 0.0 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 32.37% (45/139) | 2.1 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 48.2% (67/139) | 1.5 | 0.0 | 0.0 |
GO:0031326 | regulation of cellular biosynthetic process | 32.37% (45/139) | 2.07 | 0.0 | 0.0 |
GO:0019538 | protein metabolic process | 36.69% (51/139) | 1.87 | 0.0 | 0.0 |
GO:0051171 | regulation of nitrogen compound metabolic process | 33.09% (46/139) | 2.01 | 0.0 | 0.0 |
GO:0048519 | negative regulation of biological process | 24.46% (34/139) | 2.51 | 0.0 | 0.0 |
GO:0060255 | regulation of macromolecule metabolic process | 33.81% (47/139) | 1.96 | 0.0 | 0.0 |
GO:0009889 | regulation of biosynthetic process | 32.37% (45/139) | 2.0 | 0.0 | 0.0 |
GO:0003774 | motor activity | 9.35% (13/139) | 4.94 | 0.0 | 0.0 |
GO:0051225 | spindle assembly | 7.91% (11/139) | 5.57 | 0.0 | 0.0 |
GO:0080090 | regulation of primary metabolic process | 33.09% (46/139) | 1.92 | 0.0 | 0.0 |
GO:0003677 | DNA binding | 25.18% (35/139) | 2.36 | 0.0 | 0.0 |
GO:0007051 | spindle organization | 7.91% (11/139) | 5.51 | 0.0 | 0.0 |
GO:0070925 | organelle assembly | 7.91% (11/139) | 5.48 | 0.0 | 0.0 |
GO:0031323 | regulation of cellular metabolic process | 33.09% (46/139) | 1.9 | 0.0 | 0.0 |
GO:0019222 | regulation of metabolic process | 33.81% (47/139) | 1.78 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 48.2% (67/139) | 1.32 | 0.0 | 0.0 |
GO:0044427 | chromosomal part | 8.63% (12/139) | 4.7 | 0.0 | 0.0 |
GO:0005634 | nucleus | 64.75% (90/139) | 0.95 | 0.0 | 0.0 |
GO:0050794 | regulation of cellular process | 38.85% (54/139) | 1.42 | 0.0 | 0.0 |
GO:0016462 | pyrophosphatase activity | 15.11% (21/139) | 2.74 | 0.0 | 0.0 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 15.11% (21/139) | 2.73 | 0.0 | 0.0 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 15.11% (21/139) | 2.72 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 49.64% (69/139) | 1.08 | 0.0 | 0.0 |
GO:0050789 | regulation of biological process | 41.01% (57/139) | 1.28 | 0.0 | 0.0 |
GO:0017111 | nucleoside-triphosphatase activity | 14.39% (20/139) | 2.73 | 0.0 | 0.0 |
GO:0032502 | developmental process | 33.81% (47/139) | 1.43 | 0.0 | 0.0 |
GO:0009987 | cellular process | 61.87% (86/139) | 0.82 | 0.0 | 0.0 |
GO:0044428 | nuclear part | 13.67% (19/139) | 2.71 | 0.0 | 0.0 |
GO:0010468 | regulation of gene expression | 25.9% (36/139) | 1.7 | 0.0 | 0.0 |
GO:0003676 | nucleic acid binding | 25.18% (35/139) | 1.71 | 0.0 | 0.0 |
GO:1901564 | organonitrogen compound metabolic process | 36.69% (51/139) | 1.29 | 0.0 | 0.0 |
GO:0042127 | regulation of cell proliferation | 7.19% (10/139) | 4.08 | 0.0 | 0.0 |
GO:0000725 | recombinational repair | 5.76% (8/139) | 4.59 | 0.0 | 0.0 |
GO:0000724 | double-strand break repair via homologous recombination | 5.76% (8/139) | 4.59 | 0.0 | 0.0 |
GO:1901363 | heterocyclic compound binding | 28.78% (40/139) | 1.44 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 48.92% (68/139) | 0.94 | 0.0 | 0.0 |
GO:0006302 | double-strand break repair | 6.47% (9/139) | 4.11 | 0.0 | 0.0 |
GO:0097159 | organic cyclic compound binding | 28.78% (40/139) | 1.43 | 0.0 | 0.0 |
GO:0022607 | cellular component assembly | 13.67% (19/139) | 2.38 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 49.64% (69/139) | 0.9 | 0.0 | 0.0 |
GO:0065007 | biological regulation | 41.01% (57/139) | 1.06 | 0.0 | 0.0 |
GO:0044786 | cell cycle DNA replication | 6.47% (9/139) | 4.0 | 0.0 | 0.0 |
GO:0006468 | protein phosphorylation | 12.95% (18/139) | 2.41 | 0.0 | 0.0 |
GO:0000914 | phragmoplast assembly | 2.88% (4/139) | 7.05 | 0.0 | 0.0 |
GO:1902407 | assembly of actomyosin apparatus involved in mitotic cytokinesis | 2.88% (4/139) | 7.05 | 0.0 | 0.0 |
GO:0000912 | assembly of actomyosin apparatus involved in cytokinesis | 2.88% (4/139) | 7.05 | 0.0 | 0.0 |
GO:0001708 | cell fate specification | 5.04% (7/139) | 4.64 | 0.0 | 0.0 |
GO:0051276 | chromosome organization | 7.91% (11/139) | 3.26 | 0.0 | 0.0 |
GO:0000280 | nuclear division | 5.04% (7/139) | 4.47 | 0.0 | 0.0 |
GO:0006310 | DNA recombination | 7.91% (11/139) | 3.21 | 0.0 | 0.0 |
GO:0003006 | developmental process involved in reproduction | 20.86% (29/139) | 1.63 | 0.0 | 0.0 |
GO:0005488 | binding | 41.73% (58/139) | 0.97 | 0.0 | 0.0 |
GO:0022414 | reproductive process | 23.02% (32/139) | 1.51 | 0.0 | 0.0 |
GO:0006281 | DNA repair | 7.91% (11/139) | 3.14 | 0.0 | 0.0 |
GO:0042023 | DNA endoreduplication | 5.76% (8/139) | 3.84 | 0.0 | 1e-06 |
GO:0000278 | mitotic cell cycle | 6.47% (9/139) | 3.47 | 0.0 | 1e-06 |
GO:0008152 | metabolic process | 49.64% (69/139) | 0.79 | 0.0 | 1e-06 |
GO:0000075 | cell cycle checkpoint | 2.88% (4/139) | 6.18 | 0.0 | 1e-06 |
GO:0071103 | DNA conformation change | 3.6% (5/139) | 5.2 | 0.0 | 1e-06 |
GO:0044815 | DNA packaging complex | 2.88% (4/139) | 6.05 | 0.0 | 2e-06 |
GO:0006974 | cellular response to DNA damage stimulus | 7.91% (11/139) | 2.89 | 0.0 | 2e-06 |
GO:0006355 | regulation of transcription, DNA-templated | 20.14% (28/139) | 1.5 | 0.0 | 3e-06 |
GO:2001141 | regulation of RNA biosynthetic process | 20.14% (28/139) | 1.5 | 0.0 | 3e-06 |
GO:1903506 | regulation of nucleic acid-templated transcription | 20.14% (28/139) | 1.5 | 0.0 | 3e-06 |
GO:0016310 | phosphorylation | 12.95% (18/139) | 2.02 | 0.0 | 3e-06 |
GO:0051252 | regulation of RNA metabolic process | 20.14% (28/139) | 1.49 | 1e-06 | 3e-06 |
GO:0048285 | organelle fission | 5.04% (7/139) | 3.87 | 1e-06 | 3e-06 |
GO:0008094 | DNA-dependent ATPase activity | 3.6% (5/139) | 4.87 | 1e-06 | 4e-06 |
GO:0009957 | epidermal cell fate specification | 2.88% (4/139) | 5.73 | 1e-06 | 4e-06 |
GO:0010583 | response to cyclopentenone | 5.76% (8/139) | 3.43 | 1e-06 | 5e-06 |
GO:0007049 | cell cycle | 6.47% (9/139) | 3.03 | 2e-06 | 9e-06 |
GO:0044454 | nuclear chromosome part | 3.6% (5/139) | 4.6 | 2e-06 | 1e-05 |
GO:0043228 | non-membrane-bounded organelle | 10.79% (15/139) | 2.11 | 2e-06 | 1.1e-05 |
GO:0043232 | intracellular non-membrane-bounded organelle | 10.79% (15/139) | 2.11 | 2e-06 | 1.1e-05 |
GO:0044424 | intracellular part | 87.05% (121/139) | 0.31 | 2e-06 | 1.3e-05 |
GO:0045786 | negative regulation of cell cycle | 3.6% (5/139) | 4.37 | 4e-06 | 2.2e-05 |
GO:0051784 | negative regulation of nuclear division | 2.16% (3/139) | 6.41 | 4e-06 | 2.2e-05 |
GO:0007349 | cellularization | 2.16% (3/139) | 6.41 | 4e-06 | 2.2e-05 |
GO:0009524 | phragmoplast | 3.6% (5/139) | 4.34 | 5e-06 | 2.4e-05 |
GO:0044249 | cellular biosynthetic process | 27.34% (38/139) | 1.06 | 6e-06 | 3.2e-05 |
GO:0007093 | mitotic cell cycle checkpoint | 2.16% (3/139) | 6.22 | 7e-06 | 3.4e-05 |
GO:0045930 | negative regulation of mitotic cell cycle | 2.16% (3/139) | 5.9 | 1.5e-05 | 7.2e-05 |
GO:0005730 | nucleolus | 6.47% (9/139) | 2.64 | 1.6e-05 | 7.9e-05 |
GO:1901576 | organic substance biosynthetic process | 28.06% (39/139) | 0.97 | 2e-05 | 0.0001 |
GO:0000796 | condensin complex | 1.44% (2/139) | 7.64 | 2.5e-05 | 0.000123 |
GO:0000228 | nuclear chromosome | 2.16% (3/139) | 5.64 | 2.6e-05 | 0.000129 |
GO:0044464 | cell part | 90.65% (126/139) | 0.23 | 2.9e-05 | 0.000139 |
GO:0010948 | negative regulation of cell cycle process | 2.16% (3/139) | 5.52 | 3.4e-05 | 0.000165 |
GO:0009058 | biosynthetic process | 28.06% (39/139) | 0.92 | 4e-05 | 0.000191 |
GO:0051783 | regulation of nuclear division | 2.16% (3/139) | 5.31 | 5.4e-05 | 0.000254 |
GO:0051053 | negative regulation of DNA metabolic process | 2.16% (3/139) | 5.31 | 5.4e-05 | 0.000254 |
GO:0032993 | protein-DNA complex | 2.16% (3/139) | 5.31 | 5.4e-05 | 0.000254 |
GO:0044430 | cytoskeletal part | 4.32% (6/139) | 3.19 | 5.4e-05 | 0.000258 |
GO:0005694 | chromosome | 2.88% (4/139) | 4.21 | 6.5e-05 | 0.000302 |
GO:0000776 | kinetochore | 1.44% (2/139) | 7.05 | 7.5e-05 | 0.000343 |
GO:0030261 | chromosome condensation | 1.44% (2/139) | 7.05 | 7.5e-05 | 0.000343 |
GO:0006323 | DNA packaging | 1.44% (2/139) | 7.05 | 7.5e-05 | 0.000343 |
GO:1990939 | ATP-dependent microtubule motor activity | 1.44% (2/139) | 7.05 | 7.5e-05 | 0.000343 |
GO:0005874 | microtubule | 2.88% (4/139) | 4.08 | 9.2e-05 | 0.000419 |
GO:0006796 | phosphate-containing compound metabolic process | 15.83% (22/139) | 1.26 | 0.000112 | 0.000507 |
GO:0071174 | mitotic spindle checkpoint | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:2000816 | negative regulation of mitotic sister chromatid separation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0007094 | mitotic spindle assembly checkpoint | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0032137 | guanine/thymine mispair binding | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0000400 | four-way junction DNA binding | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0031570 | DNA integrity checkpoint | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:1905819 | negative regulation of chromosome separation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:1905818 | regulation of chromosome separation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:1902100 | negative regulation of metaphase/anaphase transition of cell cycle | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0033046 | negative regulation of sister chromatid segregation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0033047 | regulation of mitotic sister chromatid segregation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0033048 | negative regulation of mitotic sister chromatid segregation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0030071 | regulation of mitotic metaphase/anaphase transition | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0010965 | regulation of mitotic sister chromatid separation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0031577 | spindle checkpoint | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0051985 | negative regulation of chromosome segregation | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0071173 | spindle assembly checkpoint | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:1902099 | regulation of metaphase/anaphase transition of cell cycle | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0032301 | MutSalpha complex | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:1901988 | negative regulation of cell cycle phase transition | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:1901991 | negative regulation of mitotic cell cycle phase transition | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0032138 | single base insertion or deletion binding | 1.44% (2/139) | 6.64 | 0.00015 | 0.000597 |
GO:0006793 | phosphorus metabolic process | 15.83% (22/139) | 1.25 | 0.000133 | 0.0006 |
GO:0044446 | intracellular organelle part | 22.3% (31/139) | 0.99 | 0.000134 | 0.000602 |
GO:0051258 | protein polymerization | 2.16% (3/139) | 4.83 | 0.000155 | 0.000614 |
GO:0044422 | organelle part | 22.3% (31/139) | 0.99 | 0.00014 | 0.000624 |
GO:0048229 | gametophyte development | 5.04% (7/139) | 2.58 | 0.000183 | 0.000724 |
GO:0042623 | ATPase activity, coupled | 5.76% (8/139) | 2.35 | 0.000188 | 0.000741 |
GO:0099513 | polymeric cytoskeletal fiber | 2.88% (4/139) | 3.8 | 0.000196 | 0.00076 |
GO:0099512 | supramolecular fiber | 2.88% (4/139) | 3.8 | 0.000196 | 0.00076 |
GO:0099080 | supramolecular complex | 2.88% (4/139) | 3.8 | 0.000196 | 0.00076 |
GO:0099081 | supramolecular polymer | 2.88% (4/139) | 3.8 | 0.000196 | 0.00076 |
GO:0051129 | negative regulation of cellular component organization | 2.16% (3/139) | 4.7 | 0.000204 | 0.000784 |
GO:0010639 | negative regulation of organelle organization | 2.16% (3/139) | 4.7 | 0.000204 | 0.000784 |
GO:0007000 | nucleolus organization | 2.16% (3/139) | 4.64 | 0.000233 | 0.000889 |
GO:1903046 | meiotic cell cycle process | 5.04% (7/139) | 2.52 | 0.000237 | 0.0009 |
GO:0032135 | DNA insertion or deletion binding | 1.44% (2/139) | 6.31 | 0.000248 | 0.000916 |
GO:0000217 | DNA secondary structure binding | 1.44% (2/139) | 6.31 | 0.000248 | 0.000916 |
GO:0043570 | maintenance of DNA repeat elements | 1.44% (2/139) | 6.31 | 0.000248 | 0.000916 |
GO:0009558 | embryo sac cellularization | 1.44% (2/139) | 6.31 | 0.000248 | 0.000916 |
GO:0051983 | regulation of chromosome segregation | 1.44% (2/139) | 6.31 | 0.000248 | 0.000916 |
GO:0045839 | negative regulation of mitotic nuclear division | 1.44% (2/139) | 6.31 | 0.000248 | 0.000916 |
GO:0033045 | regulation of sister chromatid segregation | 1.44% (2/139) | 6.31 | 0.000248 | 0.000916 |
GO:0033043 | regulation of organelle organization | 5.04% (7/139) | 2.47 | 0.000295 | 0.001084 |
GO:0016887 | ATPase activity | 6.47% (9/139) | 2.08 | 0.0003 | 0.001097 |
GO:0043231 | intracellular membrane-bounded organelle | 74.1% (103/139) | 0.3 | 0.000338 | 0.00123 |
GO:0043227 | membrane-bounded organelle | 74.1% (103/139) | 0.3 | 0.000367 | 0.001332 |
GO:0007088 | regulation of mitotic nuclear division | 1.44% (2/139) | 6.05 | 0.000371 | 0.001337 |
GO:0006338 | chromatin remodeling | 2.16% (3/139) | 4.41 | 0.000371 | 0.001342 |
GO:0016246 | RNA interference | 2.88% (4/139) | 3.55 | 0.000388 | 0.001391 |
GO:0045910 | negative regulation of DNA recombination | 1.44% (2/139) | 5.83 | 0.000518 | 0.001843 |
GO:0000018 | regulation of DNA recombination | 1.44% (2/139) | 5.83 | 0.000518 | 0.001843 |
GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity | 2.16% (3/139) | 4.22 | 0.000554 | 0.001962 |
GO:0014070 | response to organic cyclic compound | 5.76% (8/139) | 2.11 | 0.000576 | 0.002031 |
GO:0006997 | nucleus organization | 2.16% (3/139) | 4.18 | 0.000607 | 0.002133 |
GO:0043229 | intracellular organelle | 74.1% (103/139) | 0.29 | 0.000632 | 0.002212 |
GO:0043226 | organelle | 74.1% (103/139) | 0.29 | 0.000643 | 0.002243 |
GO:0035194 | posttranscriptional gene silencing by RNA | 2.88% (4/139) | 3.35 | 0.000654 | 0.002269 |
GO:0005875 | microtubule associated complex | 1.44% (2/139) | 5.64 | 0.000689 | 0.002372 |
GO:0000710 | meiotic mismatch repair | 1.44% (2/139) | 5.64 | 0.000689 | 0.002372 |
GO:0019887 | protein kinase regulator activity | 2.16% (3/139) | 4.01 | 0.000852 | 0.002924 |
GO:0006268 | DNA unwinding involved in DNA replication | 1.44% (2/139) | 5.47 | 0.000882 | 0.003005 |
GO:2001251 | negative regulation of chromosome organization | 1.44% (2/139) | 5.47 | 0.000882 | 0.003005 |
GO:0016441 | posttranscriptional gene silencing | 2.88% (4/139) | 3.19 | 0.000985 | 0.003341 |
GO:0016787 | hydrolase activity | 16.55% (23/139) | 1.0 | 0.001049 | 0.003544 |
GO:0019207 | kinase regulator activity | 2.16% (3/139) | 3.9 | 0.001071 | 0.003607 |
GO:0030983 | mismatched DNA binding | 1.44% (2/139) | 5.31 | 0.001099 | 0.003659 |
GO:0032300 | mismatch repair complex | 1.44% (2/139) | 5.31 | 0.001099 | 0.003659 |
GO:0000786 | nucleosome | 1.44% (2/139) | 5.31 | 0.001099 | 0.003659 |
GO:0010608 | posttranscriptional regulation of gene expression | 3.6% (5/139) | 2.64 | 0.001313 | 0.004354 |
GO:0000793 | condensed chromosome | 1.44% (2/139) | 5.18 | 0.001339 | 0.004407 |
GO:1990391 | DNA repair complex | 1.44% (2/139) | 5.18 | 0.001339 | 0.004407 |
GO:0003674 | molecular_function | 84.17% (117/139) | 0.2 | 0.001536 | 0.005038 |
GO:0031497 | chromatin assembly | 1.44% (2/139) | 5.05 | 0.001602 | 0.005194 |
GO:0031507 | heterochromatin assembly | 1.44% (2/139) | 5.05 | 0.001602 | 0.005194 |
GO:0070828 | heterochromatin organization | 1.44% (2/139) | 5.05 | 0.001602 | 0.005194 |
GO:0061982 | meiosis I cell cycle process | 2.88% (4/139) | 2.96 | 0.001774 | 0.005733 |
GO:0005524 | ATP binding | 5.76% (8/139) | 1.85 | 0.001797 | 0.005784 |
GO:0032508 | DNA duplex unwinding | 1.44% (2/139) | 4.94 | 0.001887 | 0.006051 |
GO:0097435 | supramolecular fiber organization | 3.6% (5/139) | 2.49 | 0.002045 | 0.006537 |
GO:0030554 | adenyl nucleotide binding | 5.76% (8/139) | 1.81 | 0.002122 | 0.006733 |
GO:0032559 | adenyl ribonucleotide binding | 5.76% (8/139) | 1.81 | 0.002122 | 0.006733 |
GO:0032392 | DNA geometric change | 1.44% (2/139) | 4.83 | 0.002194 | 0.006935 |
GO:0051128 | regulation of cellular component organization | 5.04% (7/139) | 1.96 | 0.002316 | 0.007296 |
GO:0006298 | mismatch repair | 1.44% (2/139) | 4.73 | 0.002523 | 0.007891 |
GO:0003887 | DNA-directed DNA polymerase activity | 1.44% (2/139) | 4.73 | 0.002523 | 0.007891 |
GO:0009965 | leaf morphogenesis | 3.6% (5/139) | 2.4 | 0.002656 | 0.008277 |
GO:0035639 | purine ribonucleoside triphosphate binding | 6.47% (9/139) | 1.58 | 0.003289 | 0.010215 |
GO:0032991 | protein-containing complex | 11.51% (16/139) | 1.09 | 0.003529 | 0.010922 |
GO:0032555 | purine ribonucleotide binding | 6.47% (9/139) | 1.56 | 0.003746 | 0.011553 |
GO:0017076 | purine nucleotide binding | 6.47% (9/139) | 1.55 | 0.003786 | 0.011636 |
GO:0032553 | ribonucleotide binding | 6.47% (9/139) | 1.54 | 0.003993 | 0.012228 |
GO:0000790 | nuclear chromatin | 1.44% (2/139) | 4.39 | 0.004055 | 0.012376 |
GO:0004170 | dUTP diphosphatase activity | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0033260 | nuclear DNA replication | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0006279 | premeiotic DNA replication | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0055048 | anastral spindle assembly | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0005658 | alpha DNA polymerase:primase complex | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0009971 | anastral spindle assembly involved in male meiosis | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0072355 | histone H3-T3 phosphorylation | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0000406 | double-strand/single-strand DNA junction binding | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0035822 | gene conversion | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0016895 | exodeoxyribonuclease activity, producing 5'-phosphomonoesters | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0000403 | Y-form DNA binding | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0006311 | meiotic gene conversion | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0006287 | base-excision repair, gap-filling | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0004529 | exodeoxyribonuclease activity | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0032302 | MutSbeta complex | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0005657 | replication fork | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0008296 | 3'-5'-exodeoxyribonuclease activity | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0072354 | histone kinase activity (H3-T3 specific) | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0045005 | DNA-dependent DNA replication maintenance of fidelity | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0007053 | spindle assembly involved in male meiosis | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0018107 | peptidyl-threonine phosphorylation | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0005872 | minus-end kinesin complex | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0018210 | peptidyl-threonine modification | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0043137 | DNA replication, removal of RNA primer | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0035407 | histone H3-T11 phosphorylation | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0006269 | DNA replication, synthesis of RNA primer | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0035184 | histone threonine kinase activity | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0043625 | delta DNA polymerase complex | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0007076 | mitotic chromosome condensation | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0035402 | histone kinase activity (H3-T11 specific) | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0035405 | histone-threonine phosphorylation | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0016048 | detection of temperature stimulus | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0044774 | mitotic DNA integrity checkpoint | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0045004 | DNA replication proofreading | 0.72% (1/139) | 7.64 | 0.005026 | 0.013434 |
GO:0097367 | carbohydrate derivative binding | 6.47% (9/139) | 1.52 | 0.004431 | 0.013478 |
GO:0003684 | damaged DNA binding | 1.44% (2/139) | 4.31 | 0.004491 | 0.013612 |
GO:0005515 | protein binding | 14.39% (20/139) | 0.9 | 0.00518 | 0.013802 |
GO:0009553 | embryo sac development | 2.16% (3/139) | 3.16 | 0.004707 | 0.014217 |
GO:0090626 | plant epidermis morphogenesis | 2.88% (4/139) | 2.51 | 0.00553 | 0.014647 |
GO:0010103 | stomatal complex morphogenesis | 2.88% (4/139) | 2.51 | 0.00553 | 0.014647 |
GO:0034061 | DNA polymerase activity | 1.44% (2/139) | 4.24 | 0.004947 | 0.014842 |
GO:0003713 | transcription coactivator activity | 1.44% (2/139) | 4.24 | 0.004947 | 0.014842 |
GO:0098772 | molecular function regulator | 3.6% (5/139) | 2.13 | 0.005893 | 0.015562 |
GO:0090329 | regulation of DNA-dependent DNA replication | 1.44% (2/139) | 3.99 | 0.006976 | 0.018365 |
GO:0007129 | synapsis | 2.16% (3/139) | 2.9 | 0.0077 | 0.020212 |
GO:0004674 | protein serine/threonine kinase activity | 4.32% (6/139) | 1.78 | 0.008445 | 0.022101 |
GO:0070192 | chromosome organization involved in meiotic cell cycle | 2.16% (3/139) | 2.85 | 0.008517 | 0.022226 |
GO:0045787 | positive regulation of cell cycle | 1.44% (2/139) | 3.83 | 0.008703 | 0.022644 |
GO:0006084 | acetyl-CoA metabolic process | 2.16% (3/139) | 2.81 | 0.00909 | 0.02358 |
GO:0033554 | cellular response to stress | 8.63% (12/139) | 1.13 | 0.009212 | 0.023826 |
GO:0030337 | DNA polymerase processivity factor activity | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0010520 | regulation of reciprocal meiotic recombination | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0090306 | spindle assembly involved in meiosis | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0060631 | regulation of meiosis I | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0045128 | negative regulation of reciprocal meiotic recombination | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0110029 | negative regulation of meiosis I | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0005971 | ribonucleoside-diphosphate reductase complex | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0010342 | endosperm cellularization | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0000076 | DNA replication checkpoint | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0000404 | heteroduplex DNA loop binding | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0051447 | negative regulation of meiotic cell cycle | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0022616 | DNA strand elongation | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0000819 | sister chromatid segregation | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0045835 | negative regulation of meiotic nuclear division | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0047429 | nucleoside-triphosphate diphosphatase activity | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0005871 | kinesin complex | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0005640 | nuclear outer membrane | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0006271 | DNA strand elongation involved in DNA replication | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0048314 | embryo sac morphogenesis | 0.72% (1/139) | 6.64 | 0.010027 | 0.024431 |
GO:0006637 | acyl-CoA metabolic process | 2.16% (3/139) | 2.75 | 0.010301 | 0.02496 |
GO:0035383 | thioester metabolic process | 2.16% (3/139) | 2.75 | 0.010301 | 0.02496 |
GO:0000166 | nucleotide binding | 7.19% (10/139) | 1.24 | 0.010396 | 0.025052 |
GO:1901265 | nucleoside phosphate binding | 7.19% (10/139) | 1.24 | 0.010396 | 0.025052 |
GO:0140097 | catalytic activity, acting on DNA | 2.16% (3/139) | 2.73 | 0.010618 | 0.025517 |
GO:0003712 | transcription coregulator activity | 1.44% (2/139) | 3.73 | 0.00995 | 0.025661 |
GO:0000785 | chromatin | 1.44% (2/139) | 3.64 | 0.011272 | 0.026942 |
GO:0016444 | somatic cell DNA recombination | 1.44% (2/139) | 3.64 | 0.011272 | 0.026942 |
GO:0005575 | cellular_component | 94.96% (132/139) | 0.09 | 0.011336 | 0.027023 |
GO:0034032 | purine nucleoside bisphosphate metabolic process | 2.16% (3/139) | 2.67 | 0.01194 | 0.028234 |
GO:0033875 | ribonucleoside bisphosphate metabolic process | 2.16% (3/139) | 2.67 | 0.01194 | 0.028234 |
GO:0033865 | nucleoside bisphosphate metabolic process | 2.16% (3/139) | 2.67 | 0.01194 | 0.028234 |
GO:0045010 | actin nucleation | 2.16% (3/139) | 2.56 | 0.014474 | 0.034134 |
GO:0010434 | bract formation | 0.72% (1/139) | 6.05 | 0.015003 | 0.034372 |
GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 0.72% (1/139) | 6.05 | 0.015003 | 0.034372 |
GO:0009262 | deoxyribonucleotide metabolic process | 0.72% (1/139) | 6.05 | 0.015003 | 0.034372 |
GO:0009200 | deoxyribonucleoside triphosphate metabolic process | 0.72% (1/139) | 6.05 | 0.015003 | 0.034372 |
GO:0019692 | deoxyribose phosphate metabolic process | 0.72% (1/139) | 6.05 | 0.015003 | 0.034372 |
GO:0009394 | 2'-deoxyribonucleotide metabolic process | 0.72% (1/139) | 6.05 | 0.015003 | 0.034372 |
GO:0016728 | oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor | 0.72% (1/139) | 6.05 | 0.015003 | 0.034372 |
GO:0061731 | ribonucleoside-diphosphate reductase activity | 0.72% (1/139) | 6.05 | 0.015003 | 0.034372 |
GO:0000212 | meiotic spindle organization | 0.72% (1/139) | 6.05 | 0.015003 | 0.034372 |
GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process | 0.72% (1/139) | 6.05 | 0.015003 | 0.034372 |
GO:0080175 | phragmoplast microtubule organization | 0.72% (1/139) | 6.05 | 0.015003 | 0.034372 |
GO:0030234 | enzyme regulator activity | 2.88% (4/139) | 2.08 | 0.015136 | 0.034585 |
GO:0030838 | positive regulation of actin filament polymerization | 2.16% (3/139) | 2.53 | 0.015249 | 0.034754 |
GO:0032273 | positive regulation of protein polymerization | 2.16% (3/139) | 2.52 | 0.015646 | 0.035566 |
GO:0031334 | positive regulation of protein complex assembly | 2.16% (3/139) | 2.51 | 0.016048 | 0.036386 |
GO:1902905 | positive regulation of supramolecular fiber organization | 2.16% (3/139) | 2.49 | 0.016456 | 0.037025 |
GO:0051495 | positive regulation of cytoskeleton organization | 2.16% (3/139) | 2.49 | 0.016456 | 0.037025 |
GO:0044089 | positive regulation of cellular component biogenesis | 2.16% (3/139) | 2.49 | 0.016456 | 0.037025 |
GO:0043168 | anion binding | 6.47% (9/139) | 1.2 | 0.01725 | 0.038714 |
GO:0030833 | regulation of actin filament polymerization | 2.16% (3/139) | 2.45 | 0.017714 | 0.039655 |
GO:0008064 | regulation of actin polymerization or depolymerization | 2.16% (3/139) | 2.44 | 0.018145 | 0.040111 |
GO:0030832 | regulation of actin filament length | 2.16% (3/139) | 2.44 | 0.018145 | 0.040111 |
GO:0032956 | regulation of actin cytoskeleton organization | 2.16% (3/139) | 2.44 | 0.018145 | 0.040111 |
GO:0110053 | regulation of actin filament organization | 2.16% (3/139) | 2.44 | 0.018145 | 0.040111 |
GO:0032970 | regulation of actin filament-based process | 2.16% (3/139) | 2.44 | 0.018145 | 0.040111 |
GO:0010267 | production of ta-siRNAs involved in RNA interference | 2.16% (3/139) | 2.43 | 0.018582 | 0.040974 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 1.44% (2/139) | 3.24 | 0.018938 | 0.041654 |
GO:0032271 | regulation of protein polymerization | 2.16% (3/139) | 2.41 | 0.019025 | 0.041742 |
GO:0043254 | regulation of protein complex assembly | 2.16% (3/139) | 2.4 | 0.019474 | 0.04262 |
GO:0051716 | cellular response to stimulus | 8.63% (12/139) | 0.97 | 0.019701 | 0.042904 |
GO:0000731 | DNA synthesis involved in DNA repair | 0.72% (1/139) | 5.64 | 0.019955 | 0.042927 |
GO:0035173 | histone kinase activity | 0.72% (1/139) | 5.64 | 0.019955 | 0.042927 |
GO:0042575 | DNA polymerase complex | 0.72% (1/139) | 5.64 | 0.019955 | 0.042927 |
GO:0031261 | DNA replication preinitiation complex | 0.72% (1/139) | 5.64 | 0.019955 | 0.042927 |
GO:1905392 | plant organ morphogenesis | 3.6% (5/139) | 1.7 | 0.019681 | 0.042967 |
GO:0008017 | microtubule binding | 1.44% (2/139) | 3.21 | 0.019797 | 0.043008 |
GO:1902903 | regulation of supramolecular fiber organization | 2.16% (3/139) | 2.38 | 0.020388 | 0.043753 |
GO:0051493 | regulation of cytoskeleton organization | 2.16% (3/139) | 2.35 | 0.021326 | 0.045655 |